Article | May 20, 2020

How To Address Challenges In Oncology Drug Containment

By T. Page McAndrew

image2

Drug product containment systems comprising Daikyo Crystal Zenith® cyclic olefin polymer (COP) vials have advantages over those comprising glass vials. When matched with NovaPure® stoppers, container closure integrity (CCI) performance has been quantified for oxygen and carbon dioxide, at temperatures from room temperature through cryogenic temperatures, with excellent system performance. For these reasons, they are an excellent choice for oncology therapies, in particular those based on gene and cell therapies that require cryogenic storage.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

West Pharmaceutical Services, Inc.